The emergence of nitroxyl (HNO) as a pharmacological agent
- 1 July 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1787 (7) , 835-840
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Identification of Nitroxyl-induced Modifications in Human Platelet Proteins Using a Novel Mass Spectrometric Detection MethodMolecular & Cellular Proteomics, 2009
- Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674Circulation Research, 2009
- Nitroxyl increases force development in rat cardiac muscleThe Journal of Physiology, 2007
- Nitroxyl Anion Donor, Angeli’s Salt, Does Not Develop Tolerance in Rat Isolated AortaeHypertension, 2007
- The pharmacology of nitroxyl (HNO) and its therapeutic potential: Not just the janus face of NO11This review is dedicated to the career of Prof. Herbert T. Nagasawa, a pioneer in the field of HNO chemistry, biochemistry and pharmacology.Pharmacology & Therapeutics, 2007
- Nitroxyl Improves Cellular Heart Function by Directly Enhancing Cardiac Sarcoplasmic Reticulum Ca 2+ CyclingCirculation Research, 2007
- Detection of nitrous oxide in the neuronal nitric oxide synthase reaction by gas chromatography–mass spectrometryBiochemical and Biophysical Research Communications, 2005
- NO − Activates Soluble Guanylate Cyclase and K v Channels to Vasodilate Resistance ArteriesHypertension, 2003
- N,O-Diacylated-N-hydroxyarylsulfonamides: Nitroxyl precursors with potent smooth muscle relaxant propertiesBiochemical and Biophysical Research Communications, 1992
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988